安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- ACC AHA and ESC EACTS Guidelines for the Management of Valvular Heart . . .
Candidates for TAVR should be those older than 75 years or with high-risk (STS-Prom EuroSCORE >8) in the European guidelines, or those older than 80 years or with life expectancy <10 years in the American guidelines
- 2021 ESC EACTS Guidelines for the management of valvular heart disease
These guidelines focus on acquired VHD, are oriented towards management, and do not deal with endocarditis, congenital valve disease (including pulmonary valve disease), or recommendations concerning sports cardiology and exercise in patients with cardiovascular disease, as separate guidelines have been published by the ESC on these topics
- A Guide to Valve-in-Valve TAVR: Key Points
For the performance of redo transcatheter aortic valve (TAV) procedures (valve-in-valve TAV replacement [TAVR]), it is necessary to understand the design features of various TAV devices, their compatibility, standardized sizing, and optimal placement
- ESC EACTS Guidelines on valvular heart disease - sfcardio. fr
The ESC EACTS Guidelines represent the views of the ESC and the EACTS and were arrived at after careful consideration of the available evidence at the time they were written Health professionals are encouraged to take them fully into account when exercising their clinical judgement
- AI for TAVR, robot-guided echo and more: Key research at ESC Congress 2024
These are three upcoming ESC Congress 2024 sessions sure to interest cardiologists and patients alike: A virtual voice assistant with advanced artificial intelligence (AI) capabilities can successfully “interview” transcatheter aortic valve replacement (TAVR) patients and anticipate when there may be an increased risk of complications
- Structural heart disease review of TAVR in low-risk patients . . .
In this review, we aim to highlight the evidence supporting TAVR in low-risk patients, the guidelines for clinical use, and the continuing challenges for treatment of AS patients at both lower risk and younger ages
- Transcatheter Aortic Valve Replacement: Current Status and Future . . .
2021 ESC Guidelines Transfemoral TAVR is recommended over SAVR in patients aged >80 years or in younger patients with a life expectancy <10 years and no anatomic contraindication to transfemoral TAVR
- Transcatheter aortic valve replacement: Past, present, and future
In deciding between TAVR and surgical aortic valve replacement, clinicians evaluate various factors, including patient suitability and anatomy through preprocedural imaging, which guides prosthetic valve sizing and access site selection
|
|
|